Pharmacist's Letter Canada

August 2018 Issue

You'll see more emphasis on contraception planning in adolescents....

Rxs for gabapentin and pregabalin will continue to surge....

Steglatro (steh-GLAH-troh, ertugliflozin) will be the fourth SGLT2 inhibitor for type 2 diabetes in Canada....

More than 3 million Canadians have chronic kidney disease (CKD)....

Recall

Steglatro
ertugliflozin
An SGLT2 inhibitor for type 2 diabetes

Symtuza
darunavir/cobicistat/emtricitabine/ tenofovir alafenamide
A new combination regimen for HIV-1 infection

Foquest
methylphenidate
A new controlled-release formulation for ADHD in adults